Target Research Articles. App Notes, Case Studies. & White Papers
-
How Does EPR Spectroscopy Complement Cryo-EM?
9/30/2026
Discover how EPR complements structural maps by resolving flexible regions, detecting hidden conformational states, identifying differences between grid-based and solution conditions, and revealing the dynamic changes that connect molecular structure with biological function.
-
Characterization Of Tumor-Specific T-Cells With Modifications
9/2/2026
Explore a scalable RNA-seq approach that delivers reproducible, high-quality transcriptomic data from checkpoint-edited T-cells, uncovering gene expression changes linked to PD-1 and TIGIT deletion.
-
EPR Pulsed Dipolar Spectroscopy For Structural Biology
8/31/2026
Discover how automated EPR pulsed dipolar spectroscopy measures protein dynamics, complements Cryo-EM and AlphaFold, and delivers crucial structural insights for drug discovery.
-
Enabling Effective Passive And Active Immune Cell Targeting Strategies
8/10/2026
Targeted LNPs that bypass the liver and home to the spleen could reshape in vivo CAR T cell manufacturing. See the data behind the approach.
-
How EPR Spectroscopy Reveals Membrane Protein Structure And Dynamics
7/16/2026
Resolving dynamic states in membrane proteins is vital for drug discovery. EPR spectroscopy tracks conformational shifts in native environments, bypassing standard structural limits.
-
mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models
6/19/2026
Repeat dosing may be essential for long-term mRNA applications. Explore safety, immune-response, and efficacy findings from multiple LNP administrations, including a nine-dose evaluation over six months.
-
What Is EPR Spectroscopy? Principles, Spin Labeling, And DEER In Proteins
6/2/2026
Capturing dynamic biomolecular motion remains crucial for research. EPR spectroscopy delivers ensemble distance distributions to resolve flexible states in complex protein systems.
-
Integrating High-Content Imaging With Traditional Plate-Based Screening
5/6/2026
Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.
-
Accelerating Discovery Success With Structure-Guided Drug Design
5/6/2026
Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity
4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.